Position in ABBV
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$27,938,581
+$3,920,074 QoQ
Shares Held
111,026
+0.5% QoQ
Ownership
0.006%
of shares outstanding
% of Portfolio
2.96%
of 13F equity value
Holder Rank
#505
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cypress Capital Group holds $135,758,423 across 9 Drug Manufacturers - General names. ABBV ranks #2 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
47,680 | $57,188,826 | |
| 2 | ABBV |
AbbVie Inc.
This page
|
111,026 | $27,938,581 | |
| 3 | JNJ |
Johnson & Johnson
|
82,604 | $20,978,936 | |
| 4 | MRK |
Merck & Co., Inc.
|
62,260 | $8,000,410 | |
| 5 | AMGN |
Amgen Inc
|
18,021 | $6,525,764 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
47,312 | $5,977,398 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
84,745 | $4,883,006 | |
| 8 | PFE |
Pfizer Inc
|
138,473 | $3,334,429 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $27,938,581 | 111,026 | Shares | Defined | 2026-08-05 | |
| 2026-03-31 | $24,018,507 | 110,435 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $25,731,172 | 112,614 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $24,995,436 | 107,953 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $20,134,201 | 108,470 | Shares | Sole | 2025-07-25 | |
| 2025-03-31 | $22,542,674 | 107,592 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $19,963,883 | 112,346 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $22,472,630 | 113,797 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $19,541,444 | 113,931 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $20,915,823 | 114,859 | Shares | Defined | 2024-05-08 | |
| 2023-12-31 | $17,189,427 | 110,921 | Shares | Sole | 2024-01-24 | |
| 2023-09-30 | $16,692,035 | 111,982 | Shares | Sole | 2023-11-02 | |
| 2023-06-30 | $15,173,561 | 112,622 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $18,563,576 | 116,481 | Shares | Defined | 2023-05-04 | |
| 2022-12-31 | $20,236,803 | 125,220 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $16,054,468 | 119,622 | Shares | Sole | 2022-11-04 | |
| 2022-06-30 | $19,147,755 | 125,018 | Shares | Sole | 2022-07-26 | |
| 2022-03-31 | $21,192,478 | 130,729 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $16,311,502 | 120,469 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $14,543,140 | 134,821 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $14,932,796 | 132,571 | Shares | Sole | 2021-07-13 | |
| 2021-03-31 | $14,349,104 | 132,592 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $14,441,569 | 134,779 | Shares | Sole | 2021-01-12 | |
| 2020-09-30 | $12,072,266 | 137,827 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $13,680,104 | 139,337 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $10,143,249 | 133,131 | Shares | Sole | 2020-04-08 | |
| No filing history on record for this holder in this stock. | ||||||